Roundhill Glp-1 & Weight Loss ETF (OZEM)

$26.58 +0.08 (0.30%)
Market Cap N/A
Revenue (ttm) N/A
Net Income (ttm) N/A
EPS (ttm) N/A
PE Ratio N/A
Forward PE N/A
Profit Margin N/A
Debt to Equity Ratio N/A
Volume 14,604
Avg Vol N/A
Day's Range N/A - N/A
Shares Out N/A
Stochastic %K N/A
Beta N/A
Analysts N/A
Price Target N/A

Company Profile

The fund's manager will invest at least 80% of its net assets (plus any borrowings for investment purposes) in the equity securities of GLP-1 & Weight Loss Companies or any derivative instruments (such as swap agreements or forward contracts) that utilize one or more GLP-1 & Weight Loss Companies as the reference asset. The fund is non-diversified.

StocktwitsNews
StocktwitsNews Aug. 19 at 10:38 AM
Novo Nordisk Begins New Study Testing Smaller Doses Of Blockbuster Wegovy – A Look At Some Key Highlights $NVO $LLY $OZEM https://stocktwits.com/news/equity/markets/novo-nordisk-looks-to-expand-wegovy-pill-push-with-lower-dose-study/cZYdgkhRJkA
0 · Reply
D1gitalN0mad
D1gitalN0mad Aug. 12 at 3:26 PM
$LLY $OZEM $SPY where you guys getting that good good “Reta”
0 · Reply
StocktwitsNews
StocktwitsNews Aug. 12 at 12:05 PM
Eli Lilly Steps Up Retatrutide Crackdown With Six New Lawsuits – CMO Hyman Says Drug Sold In Black Market Is ‘Not A Medicine’ $LLY $OZEM https://stocktwits.com/news/equity/markets/eli-lilly-steps-up-retatrutide-crackdown-with-six-new-lawsuits-cmo-hyman-says-drug-sold-in-black-market-is-not-a-medicine/cZo8cvERJgr
0 · Reply
StocktwitsNews
StocktwitsNews Aug. 11 at 3:26 PM
Citi Says Hims & Hers’ Full-Year Outlook Indicates ‘Hefty’ Q4 Earnings Lift, Warns Of Execution Risks $HIMS $OZEM https://stocktwits.com/news/equity/markets/citi-says-hims-and-hers-full-year-outlook-indicates-hefty-q4-earnings-lift-warns-of-execution-risks/cZoNbc5RJQC
0 · Reply
StocktwitsNews
StocktwitsNews Aug. 10 at 5:31 PM
Eli Lilly’s GLP-1 Pill Secures First European Milestone – Here’s Everything To Know About UK MHRA’s Foundayo Approval $LLY $OZEM https://stocktwits.com/news/equity/markets/lilly-foundayo-glp-uk-approval-lly-stock/cZojxJIRJfe
0 · Reply
StocktwitsNews
StocktwitsNews Aug. 5 at 1:23 PM
Eli Lilly CEO Bets On Weight-Loss Medicine Retatrutide As Next Growth Driver, Says Firm’s Future Has ‘Never Been Brighter’ $LLY $OZEM https://stocktwits.com/news/equity/markets/eli-lilly-ceo-bets-on-weight-loss-medicine-retatrutide-as-next-growth-driver-says-firm-future-has-never-been-brighter/cZo4Ax8RJI8
0 · Reply
StocktwitsNews
StocktwitsNews Jul. 31 at 1:36 PM
NVO Stock Slumps After Late-Stage Trial Fails Primary Goal – Retail Says ‘Current Revenue Drivers’ Still Intact $NVO $OZEM https://stocktwits.com/news/equity/markets/nvo-stock-slumps-after-late-stage-trial-fails-primary-goal-retail-says-current-revenue-drivers-still-intact/cZN4B0qRJPh
0 · Reply
getshorty77
getshorty77 Jul. 28 at 2:34 PM
$OZEM New to this. Is there truly a benefit to owning it over the best pharma brand producing them?
1 · Reply
StocktwitsNews
StocktwitsNews Jul. 24 at 10:50 AM
Novo Nordisk Reportedly Escalates Legal Battle Against Eli Lilly – Even As Analysts See LLY Leading The GLP-1 Race $NVO $LLY $OZEM https://stocktwits.com/news/equity/markets/novo-nordisk-reportedly-escalates-legal-battle-against-eli-lilly-even-as-analysts-see-lly-leading-the-glp-1-race/cZZYsGBR7y1
0 · Reply
StocktwitsNews
StocktwitsNews Jul. 23 at 12:23 PM
Eli Lilly Moves Closer To Another Weight-Loss Drug: Retatrutide Clears Two More Phase 3 Trials Ahead Of FDA Filing $LLY $NVO $OZEM https://stocktwits.com/news/equity/markets/eli-lilly-moves-closer-to-another-weight-loss-drug-retatrutide-clears-two-more-phase-3-trials-ahead-of-fda-filing/cZZnFXJR7xA
0 · Reply
Latest News on OZEM
Mag7, AI and GLP-1: Roundhill CEO on the hottest ETFs to watch

Sep 12, 2024, 2:51 PM EDT - 2 years ago

Mag7, AI and GLP-1: Roundhill CEO on the hottest ETFs to watch

CHAT MAGS

Why Investors Haven't Feasted on Two New Weight-Loss ETFs

Jun 24, 2024, 7:35 PM EDT - 2 years ago

Why Investors Haven't Feasted on Two New Weight-Loss ETFs

THNR

OZEM: Investing in the Weight Loss Craze

May 29, 2024, 12:01 PM EDT - 2 years ago

OZEM: Investing in the Weight Loss Craze

This new weight loss drug ETF bets big on two of the industry's leading players

May 27, 2024, 12:01 PM EDT - 2 years ago

This new weight loss drug ETF bets big on two of the industry's leading players

New funds jump on weight loss trade

May 21, 2024, 5:02 PM EDT - 2 years ago

New funds jump on weight loss trade

Roundhill Investments Launches GLP-1 & Weight Loss ETF (OZEM)

May 21, 2024, 9:00 AM EDT - 2 years ago

Roundhill Investments Launches GLP-1 & Weight Loss ETF (OZEM)

Roundhill to launch active weight loss ETF

May 20, 2024, 1:40 PM EDT - 2 years ago

Roundhill to launch active weight loss ETF

StocktwitsNews
StocktwitsNews Aug. 19 at 10:38 AM
Novo Nordisk Begins New Study Testing Smaller Doses Of Blockbuster Wegovy – A Look At Some Key Highlights $NVO $LLY $OZEM https://stocktwits.com/news/equity/markets/novo-nordisk-looks-to-expand-wegovy-pill-push-with-lower-dose-study/cZYdgkhRJkA
0 · Reply
D1gitalN0mad
D1gitalN0mad Aug. 12 at 3:26 PM
$LLY $OZEM $SPY where you guys getting that good good “Reta”
0 · Reply
StocktwitsNews
StocktwitsNews Aug. 12 at 12:05 PM
Eli Lilly Steps Up Retatrutide Crackdown With Six New Lawsuits – CMO Hyman Says Drug Sold In Black Market Is ‘Not A Medicine’ $LLY $OZEM https://stocktwits.com/news/equity/markets/eli-lilly-steps-up-retatrutide-crackdown-with-six-new-lawsuits-cmo-hyman-says-drug-sold-in-black-market-is-not-a-medicine/cZo8cvERJgr
0 · Reply
StocktwitsNews
StocktwitsNews Aug. 11 at 3:26 PM
Citi Says Hims & Hers’ Full-Year Outlook Indicates ‘Hefty’ Q4 Earnings Lift, Warns Of Execution Risks $HIMS $OZEM https://stocktwits.com/news/equity/markets/citi-says-hims-and-hers-full-year-outlook-indicates-hefty-q4-earnings-lift-warns-of-execution-risks/cZoNbc5RJQC
0 · Reply
StocktwitsNews
StocktwitsNews Aug. 10 at 5:31 PM
Eli Lilly’s GLP-1 Pill Secures First European Milestone – Here’s Everything To Know About UK MHRA’s Foundayo Approval $LLY $OZEM https://stocktwits.com/news/equity/markets/lilly-foundayo-glp-uk-approval-lly-stock/cZojxJIRJfe
0 · Reply
StocktwitsNews
StocktwitsNews Aug. 5 at 1:23 PM
Eli Lilly CEO Bets On Weight-Loss Medicine Retatrutide As Next Growth Driver, Says Firm’s Future Has ‘Never Been Brighter’ $LLY $OZEM https://stocktwits.com/news/equity/markets/eli-lilly-ceo-bets-on-weight-loss-medicine-retatrutide-as-next-growth-driver-says-firm-future-has-never-been-brighter/cZo4Ax8RJI8
0 · Reply
StocktwitsNews
StocktwitsNews Jul. 31 at 1:36 PM
NVO Stock Slumps After Late-Stage Trial Fails Primary Goal – Retail Says ‘Current Revenue Drivers’ Still Intact $NVO $OZEM https://stocktwits.com/news/equity/markets/nvo-stock-slumps-after-late-stage-trial-fails-primary-goal-retail-says-current-revenue-drivers-still-intact/cZN4B0qRJPh
0 · Reply
getshorty77
getshorty77 Jul. 28 at 2:34 PM
$OZEM New to this. Is there truly a benefit to owning it over the best pharma brand producing them?
1 · Reply
StocktwitsNews
StocktwitsNews Jul. 24 at 10:50 AM
Novo Nordisk Reportedly Escalates Legal Battle Against Eli Lilly – Even As Analysts See LLY Leading The GLP-1 Race $NVO $LLY $OZEM https://stocktwits.com/news/equity/markets/novo-nordisk-reportedly-escalates-legal-battle-against-eli-lilly-even-as-analysts-see-lly-leading-the-glp-1-race/cZZYsGBR7y1
0 · Reply
StocktwitsNews
StocktwitsNews Jul. 23 at 12:23 PM
Eli Lilly Moves Closer To Another Weight-Loss Drug: Retatrutide Clears Two More Phase 3 Trials Ahead Of FDA Filing $LLY $NVO $OZEM https://stocktwits.com/news/equity/markets/eli-lilly-moves-closer-to-another-weight-loss-drug-retatrutide-clears-two-more-phase-3-trials-ahead-of-fda-filing/cZZnFXJR7xA
0 · Reply
Makingmillions192
Makingmillions192 Jul. 14 at 1:54 PM
$OZEM $THNR $HRTS While Big Pharma races to acquire oral GLP-1 delivery tech, this platform developer is about to drop human and next-gen animal datasets that could rewrite the market's tolerability standards. The Late-Summer Data Drop Schedule: Lexaria Bioscience: NASDAQ: LEXX Mid-August 2026 | Animal Study #2 (GLP-1-A26-2) Pharma is watching platform compatibility and PK data for tomorrow's next-gen blockbusters: Eli Lilly's retatrutide and Novo Nordisk's amycretin. Late August / Early September 2026 | Human Study #7 (GLP-1-H26-7) THE MAIN EVENT. Head-to-head 5-week steady-state human data comparing DehydraTECH-semaglutide tablets directly against Wegovy. Pharma is tracking bio-absorption and a projected ~40% reduction in GI side effects. Early September 2026 | Animal Study #1 (GLP-1-A26-1) Pharma is watching alternative novel formulations designed to bypass or improve upon traditional, erratic SNAC-inclusive carriers.
0 · Reply
TheArtOfFinancialWar
TheArtOfFinancialWar Jul. 7 at 2:28 PM
$OZEM HINT: target ozempic mass tort / bio pharma case and win billions 💰🪭🔥 out of 100 top plaintiff law firms investments of equity if only 1-2 succeed that’s a MASSIVE return on investment 😻 more than decades of investing in $SPY @mhparvez @TaoistTrader @LetsGoMets107 @Khalifha @PaPaBaZi @blancoBull @sonicmerlin
2 · Reply
JFDI
JFDI Jul. 1 at 1:08 PM
$OZEM gap n go
1 · Reply
StocktwitsNews
StocktwitsNews Jun. 17 at 12:04 PM
HIMS Stock Breaks Above $30 Ahead Of Upcoming FDA Peptide Review: Analysts Eye Next Growth Catalyst $HIMS $OZEM https://stocktwits.com/news/equity/markets/hims-stock-breakout-peptides-glp1-growth/cZK0wLiR7IV
0 · Reply
StocktwitsNews
StocktwitsNews Jun. 15 at 5:56 PM
HIMS Stock Set To Test A Crucial Resistance – Is Retail Expecting A Breakout? $HIMS $EDOC $OZEM https://stocktwits.com/news/equity/markets/hims-stock-gains-eyes-on-breakout/cZKfp1LR73n
0 · Reply
StocktwitsNews
StocktwitsNews Jun. 8 at 10:32 AM
LLY Stock Heads To Record High – Here’s Why Retail’s Bullish On Latest GLP-1 Data $LLY $OZEM https://stocktwits.com/news/equity/markets/lly-stock-heads-to-record-high-heres-why/cZ0vRnLR7G2
0 · Reply
daytradederic
daytradederic Jun. 5 at 1:02 PM
$OZEM looks like the ETF wants to finally break out.
0 · Reply
StocktwitsNews
StocktwitsNews Jun. 5 at 12:53 PM
TD Cowen Raises GLP-1 Sales Forecast To $150B By 2030 – Industry Leaders LLY, NVO To Remain Dominant $LLY $OZEM $NVO $HIMS https://stocktwits.com/news/equity/markets/td-cowen-glp1-sales-forecast-lilly-novo-to-remain-leaders/cZ0FkzQReCB
0 · Reply
Academia
Academia Jun. 3 at 1:51 PM
$SPY $QQQ $NVO $OZEM If you're on a GLP1 with the only purpose to lose a small amount of body fat....
1 · Reply
BillionerOfKing
BillionerOfKing May. 4 at 6:39 PM
$OZEM Current Stock Price: $31.40 Contracts to trade: $26.0 OZEM May 15 2026 Call Entry: $5.10 Exit: $9.38 ROI: 84% Hold ~24 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
Tankman22
Tankman22 Apr. 14 at 11:40 AM
$RKTO easy buy to north!!! Obesity is one of the worlds issues… buy up bulls to 1$ 🔥‼️ $SLNH $OZEM $IBRX $UAVS
0 · Reply